Nalpac Recalls DTF Sexual Chocolate Nationwide After FDA Finds Hidden Erectile Dysfunction Drugs

A Michigan-based distributor has pulled a sexual enhancement chocolate from the market after lab tests revealed it was spiked with undeclared prescription drugs. Nalpac Ltd. is conducting a voluntary nationwide recall of its 'DTF Sexual Chocolate' because the product contains both sildenafil and tadalafil—the active pharmaceutical ingredients in Viagra and Cialis. The presence of these potent drugs in a product marketed as a dietary supplement poses a serious health risk, especially for consumers with underlying heart conditions or those taking nitrate medications.

The recall, announced from Nalpac's headquarters in Ferndale, Michigan, covers all units of the chocolate that the company purchased and resold. The discovery of the pharmaceutical ingredients suggests the product was adulterated, a direct violation of FDA regulations that prohibit hiding active drug ingredients in supplements. Consumers are advised to stop using the product immediately and return it to the place of purchase. The company has not yet disclosed how the adulteration occurred or the volume of product already in circulation.

This incident triggers immediate scrutiny from the Food and Drug Administration and places significant regulatory pressure on Nalpac and the broader sexual enhancement supplement industry. The presence of sildenafil and tadalafil without a prescription or proper labeling exposes consumers to unmonitored drug interactions and potential adverse effects, including dangerously low blood pressure. The recall signals ongoing challenges in policing an industry rife with adulterated products and highlights the risks consumers face from supplements making unverified claims.